Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Function and Therapeutic Potential of In Vitro-Expanded Natural Killer T (NKT) Cells from Patients with Hematopoietic Malignancies.

Paul R. Rogers, Melissa Emerson, Esme Nguyen, Edward Ball, Asad Bashey, Shinichiro Kato

Blood (2007) 110 (11): 2742.

https://doi.org/10.1182/blood.V110.11.2742.2742

Published: 2007

Journal Articles

Immunogenetic Factors Determining Evolution of T-Cell Large Granular Lymphocyte Leukemia and Associated Cytopenias.

Zachary P. Nearman, BS, Marcin Wlodarski, MS, Chris Hung, BS, Evan Howe, BS, Yadira Narvaez, BS, Edward Ball, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2005) 106 (11): 2211.

https://doi.org/10.1182/blood.V106.11.2211.2211

Published: 2005

Journal Articles

The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.

Jugnu Jain, PhD, Jianguo Ma, PhD, Brinley Furey, BS, Christian Recher, MS, Cecile Demur, PhD, Srinivasu Poondru, PhD, Jianbo Zhang, PhD, Shaolan Li, MD, Brant Firestone, BS, Karen Olson, PhD, Maura Murphy, PhD, Jennifer Taylor, PhD, Greg Henkel, PhD, Edward Ball, MD, Yung-Mae Yao, PhD, Susan Almquist, MS, Russell Hoover, PhD

Blood (2004) 104 (11): 2530.

https://doi.org/10.1182/blood.V104.11.2530.2530

Published: 2004

Journal Articles

Survival Difference of AML Patients Receiving HLA Matched Sibling Allogeneic Bone Marrow Transplants (ABMT) Correlates with HLA-Cw Ligand Groups for Killer Immunoglobulin-Like Receptors (KIRs).

Ronald Sobecks, MD, Edward Ball, PhD, Lisa Rybicki, Stacey Brown, Matt Kalaycio, MD, Brad Pohlman, MD, Jaroslaw Maciejewski, MD, Brian Bolwell, MD

Blood (2004) 104 (11): 622.

https://doi.org/10.1182/blood.V104.11.622.622

Published: 2004

Journal Articles

A Prospective Randomized Trial of Buffy Coat Versus CD34-Selected Autologous Bone Marrow Support in High-Risk Breast Cancer Patients Receiving High-Dose Chemotherapy

Elizabeth J. Shpall, C. Fred LeMaistre, Kent Holland, Edward Ball, Roy B. Jones, Rein Saral, Cindy Jacobs, Shelly Heimfeld, Ronald Berenson, Richard Champlin

Blood (1997) 90 (11): 4313–4320.

https://doi.org/10.1182/blood.V90.11.4313

Published: 1997

NARROW

Function and Therapeutic Potential of In Vitro-Expanded Natural Killer T (NKT) Cells from Patients with Hematopoietic Malignancies.

Immunogenetic Factors Determining Evolution of T-Cell Large Granular Lymphocyte Leukemia and Associated Cytopenias.

The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.

Survival Difference of AML Patients Receiving HLA Matched Sibling Allogeneic Bone Marrow Transplants (ABMT) Correlates with HLA-Cw Ligand Groups for Killer Immunoglobulin-Like Receptors (KIRs).

A Prospective Randomized Trial of Buffy Coat Versus CD34-Selected Autologous Bone Marrow Support in High-Risk Breast Cancer Patients Receiving High-Dose Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Function and Therapeutic Potential of In Vitro-Expanded Natural Killer T (NKT) Cells from Patients with Hematopoietic Malignancies.

Immunogenetic Factors Determining Evolution of T-Cell Large Granular Lymphocyte Leukemia and Associated Cytopenias.

The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.

Survival Difference of AML Patients Receiving HLA Matched Sibling Allogeneic Bone Marrow Transplants (ABMT) Correlates with HLA-Cw Ligand Groups for Killer Immunoglobulin-Like Receptors (KIRs).

A Prospective Randomized Trial of Buffy Coat Versus CD34-Selected Autologous Bone Marrow Support in High-Risk Breast Cancer Patients Receiving High-Dose Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only